Conclusions from the VA-HIT study

被引：44

作者：

Rubins, HB

Robins, SJ

机构：

[1] Vet Adm Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA

[2] Boston Univ, Sch Med, Dept Med, Boston, MA USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 86卷 / 05期

关键词：

D O I：

10.1016/S0002-9149(00)01010-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The results and clinical implications of the Veterans Affairs HDL Intervention Trial are discussed, This trial showed that gemfibrozil was efficacious for the secondary prevention of coronary heart disease in men with a high prevalence of features of the metabolic syndrome and who had low high-density and low low-density lipoprotein cholesterol.

引用

页码：543 / +

页数：77

共 16 条

[11] DISTRIBUTION OF LIPIDS IN 8,500 MEN WITH CORONARY-ARTERY DISEASE [J].

RUBINS, HB ;

ROBINS, SJ ;

COLLINS, D ;

IRANMANESH, A ;

WILT, TJ ;

MANN, D ;

MAYOSMITH, M ;

FAAS, FH ;

ELAM, MB ;

RUTAN, GH ;

ANDERSON, JW ;

KASHYAP, ML ;

SCHECTMAN, G .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (17) :1196-1201

[12] Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol [J].

Rubins, HB ;

Robins, SJ ;

Collins, D ;

Fye, CL ;

Anderson, JW ;

Elam, MB ;

Faas, FH ;

Linares, E ;

Schaefer, EJ ;

Schectman, G ;

Wilt, TJ ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) :410-418

[13]

Sacks FM, 1998, CIRCULATION, V97, P1446

[14]

SACKS FM, CIRCULATION S1, V199, P100

[15] SOME CORONARY RISK-FACTORS RELATED TO THE INSULIN-RESISTANCE SYNDROME AND TREATMENT WITH GEMFIBROZIL - EXPERIENCE FROM THE HELSINKI HEART-STUDY [J].

TENKANEN, L ;

MANTTARI, M ;

MANNINEN, V .

CIRCULATION, 1995, 92 (07) :1779-1785

[16] The ABCs of cholesterol efflux [J].

Young, SG ;

Fielding, CJ .

NATURE GENETICS, 1999, 22 (04) :316-318

← 1 2 →